Back to Search Start Over

Pharmacoresistant epileptic eyelid twitching in a child with a mutation in SYNGAP1.

Authors :
Okazaki T
Saito Y
Hiraiwa R
Saitoh S
Kai M
Adachi K
Nishimura Y
Nanba E
Maegaki Y
Source :
Epileptic disorders : international epilepsy journal with videotape [Epileptic Disord] 2017 Sep 01; Vol. 19 (3), pp. 339-344.
Publication Year :
2017

Abstract

SYNGAP1 gene mutation has been associated with epilepsy which is often drug resistant, with seizure types including eyelid myoclonia. However, detailed descriptions, including ictal video-EEG, have not been reported. We report the case of a 4-year-old boy who developed recurrent epileptic eyelid twitching at 1 year and 5 months of age. Seizures gradually increased in frequency to more than 50 times per day and manifested with upward eye deviation, motion arrest, loss of consciousness, and eyelid twitching lasting for five seconds. Ictal EEG showed rhythmic, generalized slow or spike-and-wave complex activity with posterior predominance. Moderate psychomotor developmental delay and unsteady gait were also noted. Neuroimaging results were normal. Seizures were refractory to carbamazepine and levetiracetam but were reduced in frequency by ethosuximide and lamotrigine administration. Genetic analysis identified a c.3583-6 G>A mutation in the SYNGAP1 gene. SYNGAP1 gene analysis should be considered for intellectually disabled patients with early-onset drug resistant eyelid twitching and photosensitivity. Further clinical research on SYNGAP1 function may be necessary to treat epilepsy of this aetiology. [Published with video sequence on www.epilepticdisorders.com].

Details

Language :
English
ISSN :
1950-6945
Volume :
19
Issue :
3
Database :
MEDLINE
Journal :
Epileptic disorders : international epilepsy journal with videotape
Publication Type :
Academic Journal
Accession number :
28721930
Full Text :
https://doi.org/10.1684/epd.2017.0922